Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock enjoyed a major increase of 10.2% on 8/12/24. The shares closed at $11.25. However, below average trading volume at 78% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 16.0% during the last week.
Current PriceTarget Research Rating
RIGL is expected to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Rigel Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.